MARKET

ILMN

ILMN

Illumina Inc
NASDAQ
218.99
-3.09
-1.39%
Closed 14:47 11/25 EST
OPEN
222.08
PREV CLOSE
222.08
HIGH
222.08
LOW
218.61
VOLUME
470.06K
TURNOVER
0
52 WEEK HIGH
428.00
52 WEEK LOW
173.45
MARKET CAP
34.45B
P/E (TTM)
-8.2765
1D
5D
1M
3M
1Y
5Y
Addressing the Shortage of Genetic Counselors With Software
NORTHAMPTON, MA / ACCESSWIRE / November 21, 2022 / Illumina: Nearly everyone is a carrier for some kind of genetic disorder.1 (Probably even you.) Being a carrier means you inherited an abnormal copy of a gene from one parent, but you show no symptoms ...
ACCESSWIRE · 11/21 15:15
Looking Into Illumina's Return On Invested Capital
Benzinga · 11/21 14:46
Q&A With the CTO: Storing Growing Data While Reducing Environmental Impact
As the UN Climate Change Conference (COP27) convenes this month in Sharm el-Sheikh, Egypt, Sharon Vidal, global head of Corporate Social Responsibility at Illumina, talks to the company's chief technology officer, Alex Aravanis, about achieving a sustainab...
ACCESSWIRE · 11/18 17:30
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
MENLO PARK, Calif., November 17, 2022--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced findings from a fundamental substudy of the Circulating Cell-free Genome Atlas (CCGA; NCT02889978) study, ...
Business Wire · 11/17 21:05
Illumina Supports Next Generation Scientists at Genspace
Access to cutting edge genomics technology is expanding beyond the walls of industry and the conventional classroom. Illumina and The Illumina Corporate Foundation have granted Genspace in-kind product donations and a cash grant totalling over $100,000 to ...
ACCESSWIRE · 11/17 14:45
Illumina To Webcast Upcoming Investor Conferences
Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:
PR Newswire · 11/15 21:05
Elon Musk' Lost Millions' Over $8 'Blue Check' Fixation, FTX Hacker Holds $339M In Crypto, Amazon To Cut Workforce Starting This Week: Top Stories Tuesday, Nov. 15
Benzinga · 11/15 14:41
Illumina Slashes 5% Of Its Workforce
Benzinga · 11/15 14:20
More
About ILMN
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ILMN stock methods without spending real money on the virtual paper trading platform.